CME KOL Video Debate Four multidisciplinary key opinion leaders debate cutting-edge issues in 6 videos, each highlighting a different aspect of hypogonadism management. Martin M. Miner, MD (primary care), serves as Chairperson, and the faculty are Adrian S. Dobs, MD, MHS (endocrinology); Robert A. Kloner, MD, PhD (cardiology); and Abraham Morgentaler, MD (urology).

CME Newsletter Adrian S. Dobs, MD, MHS, and John E. Morley, MB, BCh, discuss the relationship between hypogonadism and osteoporosis.

CME Case Study 2 Earn free CME credit by participating in the second 3-part Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Participants may receive CME credit upon completion of each installment of the case study.

ENDO Conference Courier Report The impact of hypogonadism on men's overall health and well-being was one of the state-of-the-art topics at the Endocrine Society's 93rd Annual Meeting and Expo, held in Boston, Massachusetts, June 4 to 7, 2011. Adrian S. Dobs, MD, MHS, and Christina Wang, MD, serve as faculty for this CME activity. Earn CME credit by reviewing the TestosteroneUpdate Conference Courier Report on highlights of ENDO 2011.

AUA Conference Courier Report Hypogonadism and its impact on men's health was one of the state-of-the-art topics at the annual meeting of the American Urological Association held May 14 to 19, 2011, in Washington, DC. Martin M. Miner, MD, and Ajay Nehra, MD, serve as faculty for this CME activity. Earn CME credit by reviewing the TestosteroneUpdate Conference Courier Report on highlights of the 2011 AUA Annual Meeting.

Heart of the Matter: Hypogonadism Management With Testosterone Therapy Access materials presented at the multisponsored CME-certified symposium exploring the relationship between testosterone and cardiovascular disease held in conjunction with the AUA 2011 Annual Meeting. Allen D. Seftel, MD (Chairperson); Adrian S. Dobs, MD, MHS; Robert A. Kloner, MD, PhD; and Martin M. Miner, MD, provided multidisciplinary perspectives on current debates regarding screening, diagnosis, and therapeutic options for hypogonadism.

CME Newsletter Abdulmaged M. Traish, MBA, PhD, and Andre T. Guay, MD, examine the interrelationship of type 2 diabetes, insulin resistance, and hypogonadism, discuss the pathophysiologic link, and offer treatment strategies.

CME Newsletter Glenn R. Cunningham, MD, and Robert S. Tan, MD, MBA, survey the range of testosterone formulations, focusing on the gels currently available and those in development, and offer clinical tips for optimizing safety, efficacy, and adherence.

CME Newsletter Ronald S. Swerdloff, MD, and Wayne J.G. Hellstrom, MD, respond to public confusion of anabolic-androgenic steroid abuse and testosterone therapy.

CME Case Study—Part 3 Earn free CME credit by participating in the 3-part TU CME Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Participants may receive CME credit upon completion of each installment of the case study.

CME Newsletter Ronald S. Swerdloff, MD, and Adrian S. Dobs, MD, MHS, evaluate the research exploring the association between testosterone and cardiovascular disease.

ENDO Conference Courier Highlights The treatment of hypogonadism was one of the state-of-the-art topics at the annual meeting of the Endocrine Society held in San Diego, California, June 19 to 22, 2010.

AUA Conference Courier Highlights Hypogonadism and its impact on men’s health was one of the state-of-the-art topics at the annual meeting of the American Urological Association held May 29 to June 3, 2010, in San Francisco, California.

CME Case Study—Part 2 Earn free CME credit by participating in the 3-part TU CME Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Participants may receive CME credit upon completion of each installment of the case study.

CME Case Study—Part 1 Earn free CME credit by participating in the 3-part TU CME Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Participants may receive CME credit upon completion of each installment of the case study.

Downloadable TU Toolkit Four clinical tools support hypogonadism diagnosis, management, and patient care, including tips on raising patient awareness about hypogonadism.

Testosterone Update Town Hall Forum Proceedings TestosteroneUpdate Distinguished Faculty convened to discuss cutting-edge information concerning the diagnosis and treatment of hypogonadism, with the goal of increasing awareness about this underrecognized and undertreated condition. Earn up to 1.5 AMA PRA Category 1 Credits™.

American Urological Association Conference Courier Highlights Report on Hypogonadism The treatment of hypogonadism was one of the state-of-the-art topics at the annual meeting of the American Urological Association held April 25 to April 30, 2009, in Chicago, Illinois.

Endocrine Society Conference Courier Highlights Report on Hypogonadism The treatment of hypogonadism was one of the state-of-the-art topics at the annual meeting of the Endocrine Society held in Washington, DC, June 10 to 13, 2009.

Frequently Asked Questions This downloadable reference guide answers commonly asked questions about the diagnosis, management, and treatment of hypogonadism. Topics include comorbidities, efficacy and safety of testosterone therapy, and tips for optimizing long-term persistence with testosterone therapy and treatment success.

Highlights From Disease State Theater Experts from the fields of endocrinology, primary care, and urology presented at the 2008 American Urological Association and Endocrine Society annual meetings on treatment of hypogonadism in men. The proceedings from these meetings review the current data on hypogonadism and offer recommendations that can be incorporated into your clinical practice.

Multidisciplinary Insights Into the Assessment, Diagnosis, and Management of Hypogonadism Experts from the fields of endocrinology, primary care, and urology participated in a roundtable discussion focusing on the diagnosis and treatment of hypogonadism in men.

Proceedings From the TU 1st Annual Conference on Improving Clinical Outcomes in Hypogonadism Physicians at the forefront of treatment and research presented and discussed treatment considerations in the management of hypogonadism.

Emerging Evidence and Future Directions in Treating Hypogonadism This informative monograph was co-authored by Adrian S. Dobs, MD, MHS, and Frances J. Hayes, MD.

Optimizing Patient Safety in the Management of Hypogonadism This satellite symposium was presented at the 16th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists.

Bridging the Treatment Gaps in the Management of Hypogonadism In this paper, faculty address issues facing clinicians who treat men with hypogonadism.